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tissue plasminogen activator (tPA) expression by endothelial cells while levels of its inhibitor (PAI) are 
decreased by the drug. Apart from its fibrinolytic activity, PPS mobilise lipids through release of bound 
lipases, as well as SOD and platelet factor 4, from endothelial nd hepatic ells. Recent findings of decreased 
levels of osteocalcin in SF of PPS-treated OA patients uggests that osteoclast  activity may also be 
modulated by this drug, however this preliminary finding has yet to be confirmed. 
While disease modification in OA could be considered as the "Holy Grail" of rheumatology, many have 
questioned its reality. However, mounting data on the pharmacology of PPS suggests that we may shortly 
be in a position to challenge this dogma. 
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Disease modifying properties of sodium pentosan polysulphate (NaPPS) and insulin-like growth factor-1 
(IGF-1) in osteoarthritis (OA) were assessed in the Pond-Nuki canine cruciate deficiency model of OA. There 
were 5 groups of animals: N= unoperated controls; C = operated controls; PPS = intramuscular PPS, 2 mg/kg 
weeks 4 through 6; IGF-1 = intraarticular IGF-1 1 #g three times each week from week 4 through 6; 
PPS/ IGF-1  = both PPS and IGF-1 in the above regimen. At 6 weeks, femoral condylar cartilage was assessed 
for anatomy, histology (Mankin score) and biochemistry. 
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Results 
Anatomy: PPS/ IGF-1  approximated N.
Histology: PPS and PPS/ IGF-1  less severe than OA. 
Biochemistry: PPS had less enzyme than OA for active neutral metalloproteinase. PPS/ IGF-1  had near N 
active and total neutral metalloproteinase, tissue inhibitor of metalloproteinase, total 
collagenase, uronate and hydroxyproline. 
Conclusion 
NaPPS and particularly NaPPS combined with IGF-1 was able to interfere with the progression of OA in 
an animal model. It is hypothesized that proteinase activity was blocked by the NaPPS. The absence of 
effective proteinase activity is hypothesized to permit growth factor stimulation. 
Since it appears that a combination ofagents will be needed to effectively modify cartilage metabolism, this 
approach to therapeutics appears to be a rationale approach to disease modification i  OA. 
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Introduct ion 
In an established rabbit model of inflammatory arthritis induced by intra-articular injection of a hyaluronan 
poly-D-lysine complex (PC), calcium pentosan polysulphate (CaPPS, 10 mg/kg orally) demonstrated a 
